Form 4: Supernus Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Frank Mottola, SVP at Supernus Pharmaceuticals, disposed of shares to cover tax withholding requirements related to vesting Restricted Stock Units.
Summary
- On March 5, 2025, Frank Mottola, SVP at Supernus Pharmaceuticals, disposed of shares of common stock to satisfy tax withholding requirements.
- The transactions involved the disposal of 337, 610, and 945 shares at a price of $33.05 per share.
- Following these transactions, Mottola's direct ownership of Supernus Pharmaceuticals common stock is 13,882 shares.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. They are often related to stock options or restricted stock units vesting and can be used to cover tax obligations or for personal financial planning.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock disposal transactions to cover tax withholding. |
Keywords
Form 4, Supernus Pharmaceuticals, SUPN, Frank Mottola, Stock Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.